The authors of these posters are:

  • Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)
  • Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain
  • Unidad Mixta de Terapias Avanzadas. Instituto de Investigación Sanitaria Fundación Jiménez
  • VIVEbiotech (responsible for the manufacturing of Lentiviral vectors)

As shown in the poster, this work has been finanzed with the support of the USA-based leader Company in Gene Therapy, Rocket Pharma.

Once this poster is presented, it will be shown at VIVEbiotech´s webpage.